California bill would eliminate “learned intermediary” defense
Executive Summary
A bill introduced in California Feb. 22 would declare that "manufacturers of prescription pharmaceutical products shall not be relieved of a duty to warn consumers of the risks and side effects solely because the product was prescribed to a patient by a physician." This would strip away the learned intermediary defense, which holds that a drug manufacturer does not need to warn each patient of a product's risks if it warns the prescribing physician. The West Virginia Supreme Court is the only court that has rejected the doctrine (1"The Pink Sheet," Nov. 26, 2007, p. 15)
You may also be interested in...
Pharma Companies Swat Down Novel Theories Of Product Liability
For the last five years, brand name companies have been pulled into court to battle claims that they are liable for injuries caused by a generic version of their drug
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.